Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
Omima S. Mohammed(Najran University), Hany M. Fayed(Institute of Clinical Research), Marawan A. Elbaset(National Research Centre), Bassim M. S. A. Mohamed(National Research Centre), Hany G. Attia(Najran University)
Cited by 39
Related Papers
The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats
|PLoS ONE|2021|48
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats
|Chemico-Biological Interactions|2018|47